Dynavax and AstraZeneca to succeed TLR-9 Agonist Into Clinic for Bronchial asthma

BERKELEY, CA -- (MARKET WIRE) -- 10/05/11 -- Dynavax

Technologies Corporation (NASDAQ: DVAX) and AstraZeneca have

amended their existing Collaboration Agreement to accelerate the

initiation of clinical growth and development of AZD 1419, a... (Source: Drugs.com - Pharma News)

MedWorm Sponsor Message: Please offer the DoctorsInChains.org campaign for that health employees in Bahrain. #FreeDoctors

More details: Check this...

Tags: Health, asthma, nasdaq, drugs, health workers

Tags: , , , ,

No comments yet.

Leave a Reply